title: Evidence for 20 mg aspirin (ASA) as being optimal.
authors.affiliation: Atherosclerosis Research Group (ASF) Vienna, Austria.
authors.forename: H
authors.initials: H
authors.lastname: Sinzinger
authors.forename: I
authors.initials: I
authors.lastname: Virgolini
authors.forename: R
authors.initials: R
authors.lastname: Eyb
authors.forename: P
authors.initials: P
authors.lastname: Fitscha
authors.forename: J
authors.initials: J
authors.lastname: Kaliman
mesh_terms: D001095:Arachidonic Acids / Q000097:blood; D001241:Aspirin / Q000494:pharmacology* / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011453:Prostaglandins / Q000502:physiology*; D011897:Random Allocation; D012016:Reference Values; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D001095:Arachidonic Acids; D011453:Prostaglandins; D001241:Aspirin